Literature DB >> 27216631

Co-culture model consisting of human brain microvascular endothelial and peripheral blood mononuclear cells.

Marianne Strazza1, Monique E Maubert2, Vanessa Pirrone3, Brian Wigdahl4, Michael R Nonnemacher5.   

Abstract

BACKGROUND: Numerous systems exist to model the blood-brain barrier (BBB) with the goal of understanding the regulation of passage into the central nervous system (CNS) and the potential impact of selected insults on BBB function. These models typically focus on the intrinsic cellular properties of the BBB, yet studies of peripheral cell migration are often excluded due to technical restraints. NEW
METHOD: This method allows for the study of in vitro cellular transmigration following exposure to any treatment of interest through optimization of co-culture conditions for the human brain microvascular endothelial cells (BMEC) cell line, hCMEC/D3, and primary human peripheral blood mononuclear cells (PBMCs).
RESULTS: hCMEC/D3 cells form functionally confluent monolayers on collagen coated polytetrafluoroethylene (PTFE) transwell inserts, as assessed by microscopy and tracer molecule (FITC-dextran (FITC-D)) exclusion. Two components of complete hCMEC/D3 media, EBM-2 base-media and hydrocortisone (HC), were determined to be cytotoxic to PBMCs. By combining the remaining components of complete hCMEC/D3 media with complete PBMC media a resulting co-culture media was established for use in hCMEC/D3-PBMC co-culture functional assays. COMPARISON WITH EXISTING
METHODS: Through this method, issues of extensive differences in culture media conditions are resolved allowing for treatments and functional assays to be conducted on the two cell populations co-cultured simultaneously.
CONCLUSION: Described here is an in vitro co-culture model of the BBB, consisting of the hCMEC/D3 cell line and primary human PBMCs. The co-culture media will now allow for the study of exposure to potential insults to BBB function over prolonged time courses.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Blood–brain barrier; Brain microvascular endothelial cells; Peripheral blood mononuclear cells; hCMEC/D3 cell line

Mesh:

Substances:

Year:  2016        PMID: 27216631      PMCID: PMC4925208          DOI: 10.1016/j.jneumeth.2016.05.016

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  29 in total

1.  Chemokine-dependent mechanisms of leukocyte trafficking across a model of the blood-brain barrier.

Authors:  E A Eugenin; Joan W Berman
Journal:  Methods       Date:  2003-04       Impact factor: 3.608

2.  Immune surveillance of the normal human CNS takes place in dependence of the locoregional blood-brain barrier configuration and is mainly performed by CD3(+)/CD8(+) lymphocytes.

Authors:  Christian Loeffler; Klaus Dietz; Ariane Schleich; Holger Schlaszus; Manuel Stoll; Richard Meyermann; Michel Mittelbronn
Journal:  Neuropathology       Date:  2010-11-24       Impact factor: 1.906

3.  Induction of various blood-brain barrier properties in non-neural endothelial cells by close apposition to co-cultured astrocytes.

Authors:  Y Hayashi; M Nomura; S Yamagishi; S Harada; J Yamashita; H Yamamoto
Journal:  Glia       Date:  1997-01       Impact factor: 7.452

4.  Focal MMP-2 and MMP-9 activity at the blood-brain barrier promotes chemokine-induced leukocyte migration.

Authors:  Jian Song; Chuan Wu; Eva Korpos; Xueli Zhang; Smriti M Agrawal; Ying Wang; Cornelius Faber; Michael Schäfers; Heinrich Körner; Ghislain Opdenakker; Rupert Hallmann; Lydia Sorokin
Journal:  Cell Rep       Date:  2015-02-19       Impact factor: 9.423

5.  Aryl hydrocarbon receptor regulates CYP1B1 but not ABCB1 and ABCG2 in hCMEC/D3 human cerebral microvascular endothelial cells after TCDD exposure.

Authors:  Aude Jacob; Sophie Potin; Hélène Chapy; Dominique Crete; Fabienne Glacial; Kayathiri Ganeshamoorthy; Pierre-Olivier Couraud; Jean-Michel Scherrmann; Xavier Declèves
Journal:  Brain Res       Date:  2015-04-07       Impact factor: 3.252

6.  Neuropathology associated with feline immunodeficiency virus infection highlights prominent lymphocyte trafficking through both the blood-brain and blood-choroid plexus barriers.

Authors:  Gavin Ryan; Terence Grimes; Brenda Brankin; Mohamad J E M F Mabruk; Margaret J Hosie; Oswald Jarrett; John J Callanan
Journal:  J Neurovirol       Date:  2005-08       Impact factor: 2.643

7.  PPARalpha and PPARgamma attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities.

Authors:  Wen Huang; Sung Yong Eum; Ibolya E András; Bernhard Hennig; Michal Toborek
Journal:  FASEB J       Date:  2009-01-13       Impact factor: 5.191

8.  Immortalized human brain endothelial cells and flow-based vascular modeling: a marriage of convenience for rational neurovascular studies.

Authors:  Luca Cucullo; Pierre-Olivier Couraud; Babette Weksler; Ignacio-Andres Romero; Mohammed Hossain; Edward Rapp; Damir Janigro
Journal:  J Cereb Blood Flow Metab       Date:  2007-07-04       Impact factor: 6.200

9.  Carcinoembryonic antigen-related cell adhesion molecule 1 inhibits MMP-9-mediated blood-brain-barrier breakdown in a mouse model for ischemic stroke.

Authors:  Peter Ludewig; Jan Sedlacik; Mathias Gelderblom; Christian Bernreuther; Yücel Korkusuz; Christoph Wagener; Christian Gerloff; Jens Fiehler; Tim Magnus; Andrea Kristina Horst
Journal:  Circ Res       Date:  2013-06-18       Impact factor: 17.367

10.  Transcriptional profiling of human brain endothelial cells reveals key properties crucial for predictive in vitro blood-brain barrier models.

Authors:  Eduard Urich; Stanley E Lazic; Juliette Molnos; Isabelle Wells; Per-Ola Freskgård
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

View more
  7 in total

Review 1.  New experimental models of the blood-brain barrier for CNS drug discovery.

Authors:  Mohammad A Kaisar; Ravi K Sajja; Shikha Prasad; Vinay V Abhyankar; Taylor Liles; Luca Cucullo
Journal:  Expert Opin Drug Discov       Date:  2016-11-07       Impact factor: 6.098

2.  Cell Interplay Model to Assess the Impact of Glioma Cells on Blood-Brain Barrier Permeability.

Authors:  Cláudia Martins; Bruno Sarmento
Journal:  Methods Mol Biol       Date:  2022

3.  p95HER2-T cell bispecific antibody for breast cancer treatment.

Authors:  Irene Rius Ruiz; Rocio Vicario; Beatriz Morancho; Cristina Bernadó Morales; Enrique J Arenas; Sylvia Herter; Anne Freimoser-Grundschober; Jitka Somandin; Johannes Sam; Oliver Ast; Águeda Martinez Barriocanal; Antonio Luque; Marta Escorihuela; Ismael Varela; Isabel Cuartas; Paolo Nuciforo; Roberta Fasani; Vicente Peg; Isabel Rubio; Javier Cortés; Violeta Serra; Santiago Escriva-de-Romani; Jeff Sperinde; Ahmed Chenna; Weidong Huang; John Winslow; Joan Albanell; Joan Seoane; Maurizio Scaltriti; Jose Baselga; Josep Tabernero; Pablo Umana; Marina Bacac; Cristina Saura; Christian Klein; Joaquín Arribas
Journal:  Sci Transl Med       Date:  2018-10-03       Impact factor: 17.956

4.  Establishment of a Human iPSC- and Nanofiber-Based Microphysiological Blood-Brain Barrier System.

Authors:  Dianjun Qi; Shaohua Wu; Haishuang Lin; Mitchell A Kuss; Yuguo Lei; Alexey Krasnoslobodtsev; Shaheen Ahmed; Chi Zhang; Hyung Joon Kim; Peng Jiang; Bin Duan
Journal:  ACS Appl Mater Interfaces       Date:  2018-06-22       Impact factor: 9.229

Review 5.  Review of Design Considerations for Brain-on-a-Chip Models.

Authors:  Tiffany Cameron; Tanya Bennet; Elyn M Rowe; Mehwish Anwer; Cheryl L Wellington; Karen C Cheung
Journal:  Micromachines (Basel)       Date:  2021-04-15       Impact factor: 2.891

6.  Chronic Low Dose Morphine Does Not Alter Two In Vitro BBB Models.

Authors:  Jamie Marino; Monique E Maubert; Jill M Lawrence; Brian Wigdahl; Michael R Nonnemacher
Journal:  Brain Sci       Date:  2022-07-06

7.  Bacteria elevate extracellular adenosine to exploit host signaling for blood-brain barrier disruption.

Authors:  Zunquan Zhao; Xueyi Shang; Ying Chen; Yuling Zheng; Wenhua Huang; Hua Jiang; Qingyu Lv; Decong Kong; Yongqiang Jiang; Peng Liu
Journal:  Virulence       Date:  2020-12       Impact factor: 5.882

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.